U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756515) titled 'Chatbot Implementation In The Clinical Informed Consent Process' on Aug. 07.
Brief Summary: The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Study Start Date: Jan. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Informed Consent
Intervention:
OTHER: CoCo Chatbot
A patient-facing chatbot designed to obtain informed consent
Recru...